FindTrial
Sign In

Jatkuvan haavapuudutuksen vaikutukset tavanomaiseen kipulääkitykseen lapsipotilailla sydänleikkauksen jälkeen

Jatkuvan haavapuudutuksen vaikutukset tavanomaiseen kipulääkitykseen lapsipotilailla sydänleikkauksen jälkeen

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-008380-94-FI
Enrollment
Unknown
Registered
2009-02-02
Start date
2009-10-05
Completion date
Unknown
Last updated
2014-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tutkittavilla lapsilla on leikkaushoitoa vaativa sydämen eteisten tai kammioiden välinen aukko MedDRA version: 9.1 Level: LLT Classification code 10047301 Term: Ventricular septal defect repair MedDRA version: 9.1 Level: LLT Classification code 10003667 Term: Atrial septal defect repair

Interventions

Trade Name: Naropin Pharmaceutical Form: INN or Proposed INN: Ropivacaine Hydrochloride Pharmaceutical form of the placebo: Solution for infusion Route of administration of the placebo: Infiltration

Sponsors

Helsinki University Central Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? yes Number of subjects for this age range: F.1.2 Adults (18-64 years) F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026